A.P. Pharma (Nasdaq: APPA) has entered into a license and development agreement with Merial, a world leading animal health company ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE